NCT04531657View on ClinicalTrials.gov

Influenza Vaccine in Lung Transplant Patients - Seroprotection

CompletedOBSERVATIONAL
Enrollment

79

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Influenza
Interventions
DRUG

Influenza vaccine

influenza vaccine 0.5 ml intramuscularly during 2008-2009 season for measurement of A/Brisbane/59/2007(H1N1)-like, A/Brisbane/10/2007(H3N2)-like, and B/Florida/4/2006-like antigens

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT04531657 - Influenza Vaccine in Lung Transplant Patients - Seroprotection | Biotech Hunter | Biotech Hunter